1 t in survival, more attention has focused on
postmastectomy breast reconstruction (PBR).
2 Purpose The goals of immediate
postmastectomy breast reconstruction are to minimize def
3 Although
postmastectomy breast reconstruction can restore quality
4 with stages 0-III breast cancer considering
postmastectomy breast reconstruction with no previous re
5 The only grade 4 toxicity of
postmastectomy chemotherapy was hematologic (10%).
6 RT) were postlumpectomy breast or (optional)
postmastectomy chest wall.
7 The role of
postmastectomy chest-wall irradiation in patients with b
8 he tumor bed plus a 1-2-cm margin defined at
postmastectomy CT.
9 ed to determine whether a 3-week schedule of
postmastectomy hypofractionated radiotherapy is as effic
10 Postmastectomy hypofractionated radiotherapy was non-inf
11 knowledge, no randomised study has compared
postmastectomy hypofractionated radiotherapy with conven
12 from randomized trials testing the value of
postmastectomy irradiation and a meta-analysis of 78 ran
13 She is referred for consideration of
postmastectomy irradiation.
14 ience high rates of LRR and may benefit from
postmastectomy irradiation.
15 Postmastectomy or regional radiotherapy was prohibited.
16 Clinicians may offer
postmastectomy radiation (RT) with regional nodal irradi
17 studies are needed to determine the value of
postmastectomy radiation for patients with stage II brea
18 New indications for
postmastectomy radiation have caused a dramatic increase
19 vement of pCR does not preclude the need for
postmastectomy radiation if warranted by the pretreatmen
20 rom postmastectomy radiation, but the use of
postmastectomy radiation in N0 patients is not supported
21 Randomized trials have demonstrated that
postmastectomy radiation reduces LRR, but no overall sur
22 has analyzed the changing patterns of use of
postmastectomy radiation therapy (PMRT) during the perio
23 The use of
postmastectomy radiation therapy (PMRT) has been recomme
24 Evolving data on the effectiveness of
postmastectomy radiation therapy (PMRT) have led to chan
25 Postmastectomy radiation therapy (PMRT) improves local-r
26 Clinical trials indicate that
postmastectomy radiation therapy (PMRT) improves surviva
27 guideline provides recommendations on use of
postmastectomy radiation therapy (PMRT) in breast cancer
28 Purpose Conventionally fractionated
postmastectomy radiation therapy (PMRT) takes approximat
29 chemotherapy or hormonal therapy and without
postmastectomy radiation therapy (PMRT).
30 guiding decisions on who might benefit from
postmastectomy radiation therapy after upfront chemother
31 stablished which patients might benefit from
postmastectomy radiation therapy after upfront surgery,
32 ical trial data are needed to assess whether
postmastectomy radiation therapy can be safely omitted i
33 For CPS+EG scores >/=3, use of
postmastectomy radiation therapy decreases the likelihoo
34 %), mastectomy in 297 (17%) and mastectomy +
postmastectomy radiation therapy in 744 (44%).
35 and breast reconstruction, particularly when
postmastectomy radiation therapy is anticipated.
36 In summary,
postmastectomy radiation therapy moderately increases th
37 mastectomy alone, or mastectomy followed by
postmastectomy radiation therapy was recorded.
38 mor board recommended adjuvant chemotherapy,
postmastectomy radiation therapy, and endocrine therapy.
39 ars to be a function of the portals used for
postmastectomy radiation therapy, which do not expose th
40 nd can be used to tailor recommendations for
postmastectomy radiation therapy.
41 and > or =10 years, respectively, following
postmastectomy radiation therapy.
42 h axillary lymph node dissection (ALND), and
postmastectomy radiation therapy.
43 llary lymph node metastases may benefit from
postmastectomy radiation, but the use of postmastectomy
44 In patients undergoing
postmastectomy radiation, the use of autologous reconstr
45 Prior studies have found that
postmastectomy radiotherapy (PMRT) for breast cancer (BC
46 As the use of breast reconstruction and
postmastectomy radiotherapy (PMRT) has increased over th
47 So far, studies investigating proton
postmastectomy radiotherapy (PMRT) have used conventiona
48 For patients who receive
postmastectomy radiotherapy (PMRT), the addition of axil
49 linical Oncology guideline concerning use of
postmastectomy radiotherapy (PMRT).
50 tectomy without immediate reconstruction and
postmastectomy radiotherapy [PMRT]) represents guideline
51 isease-free and overall survival benefits of
postmastectomy radiotherapy for patients in particular p
52 r features having mastectomy if the need for
postmastectomy radiotherapy is clear with the finding of
53 Postmastectomy radiotherapy may adversely affect breast
54 Patients receiving
postmastectomy radiotherapy were excluded.
55 apy without RNI; 0.11% after mastectomy with
postmastectomy radiotherapy; and 1.7% after mastectomy w
56 Methods Women undergoing immediate
postmastectomy reconstruction for invasive cancer and/or
57 image gains continued to manifest at 2 years
postmastectomy reconstruction.
58 gh LRR rates in patients who did not receive
postmastectomy RT were lower in the AC+T arm, the differ